People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...

The study will evaluate the safety, tolerability and pharmacokinetic characteristics of the company's exenatide implant.

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...

E arlier this month, Kourtney Kardashian’s supplement brand, Lemme, joined the growing market for Ozempic dupes with the ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Ozempic continues to surge in popularity for managing type 2 diabetes and off-label weight loss, but are there natural ...

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...

A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.